AdventHealth Orlando ( Site 0003) — Orlando, Florida

AdventHealth Orlando ( Site 0003) is a clinical research site located in Orlando, Florida, United States 32804.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

AdventHealth Orlando ( Site 0003) has participated in 1 clinical trials.

Therapeutic areas: Triple-negative Breast Cancer, Non-squamous Non-small-cell Lung Cancer, NSCLC.

Sponsors: VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for AdventHealth Orlando ( Site 0003)?

AdventHealth Orlando ( Site 0003) has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has AdventHealth Orlando ( Site 0003) conducted?

AdventHealth Orlando ( Site 0003) has 1 clinical trials on record. Their work covers Triple-negative Breast Cancer, Non-squamous Non-small-cell Lung Cancer, NSCLC.

Is AdventHealth Orlando ( Site 0003) accredited by Crixeo Health?

AdventHealth Orlando ( Site 0003) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about AdventHealth Orlando ( Site 0003)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.